Holdings of HealthInvest Small & Mid Cap Healthcare
Atle Fund Management AB · Original filing · Compare with another fund · Report an error
- Net assets
- 995.9M SEK including 977.1M SEK in equities, 98.1 %
- Positions
- 39 in 9 countries
- Top ten
- 45.5 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Bridgebio Pharma Inc | 81,499 | 57.3M SEK | 5.75 % |
| 2 | Swedish Orphan Biovitrum AB | 129,234 | 50.7M SEK | 5.09 % |
| 3 | BEONE MEDICINES LTD | 17,023 | 47.9M SEK | 4.81 % |
| 4 | Cardinal Health, Inc. | 22,565 | 45.1M SEK | 4.53 % |
| 5 | Mirum Pharmaceuticals Inc | 50,964 | 44.6M SEK | 4.48 % |
| 6 | UCB SA | 15,752 | 44.6M SEK | 4.47 % |
| 7 | Genmab A/S | 16,435 | 41.2M SEK | 4.14 % |
| 8 | Revolution Medicines Inc | 44,691 | 41.2M SEK | 4.13 % |
| 9 | Alkermes PLC | 121,008 | 40.5M SEK | 4.07 % |
| 10 | Ionis Pharmaceuticals Inc | 55,818 | 39.7M SEK | 3.98 % |
| 11 | Almirall SA | 267,083 | 35.5M SEK | 3.57 % |
| 12 | Krystal Biotech Inc | 13,813 | 33.8M SEK | 3.39 % |
| 13 | Camurus AB | 70,480 | 32.9M SEK | 3.30 % |
| 14 | Neurocrine Biosciences Inc | 25,268 | 31.5M SEK | 3.16 % |
| 15 | Incyte Corp | 33,411 | 29.8M SEK | 2.99 % |
| 16 | Argenx SE | 4,365 | 29.7M SEK | 2.98 % |
| 17 | Ypsomed Holding AG | 8,813 | 28.8M SEK | 2.89 % |
| 18 | H Lundbeck A/S | 484,603 | 28.3M SEK | 2.84 % |
| 19 | Galderma Group AG | 15,108 | 27.4M SEK | 2.76 % |
| 20 | Newamsterdam Pharma Co NV | 88,784 | 26.9M SEK | 2.70 % |
| 21 | IRhythm Holdings Inc | 23,347 | 26.1M SEK | 2.62 % |
| 22 | Celcuity Inc | 21,674 | 23.4M SEK | 2.35 % |
| 23 | BoneSupport Holding AB | 115,990 | 22.6M SEK | 2.27 % |
| 24 | Abivax SA | 18,044 | 19M SEK | 1.91 % |
| 25 | Devyser Diagnostics AB | 193,222 | 14.6M SEK | 1.47 % |
| 26 | Ideaya Biosciences Inc | 41,136 | 13M SEK | 1.30 % |
| 27 | Disc Medicine Inc | 20,621 | 12.5M SEK | 1.25 % |
| 28 | Tango Therapeutics Inc | 53,936 | 10.7M SEK | 1.07 % |
| 29 | Spyre Therapeutics Inc | 21,628 | 10.3M SEK | 1.04 % |
| 30 | Sectra AB | 42,568 | 9.6M SEK | 0.97 % |
| 31 | Compass Therapeutics Inc | 181,392 | 9.1M SEK | 0.91 % |
| 32 | BioArctic AB | 24,659 | 7.9M SEK | 0.79 % |
| 33 | Hansa Biopharma AB | 233,653 | 7.4M SEK | 0.75 % |
| 34 | Bicara Therapeutics Inc | 38,945 | 7.3M SEK | 0.74 % |
| 35 | Soleno Therapeutics Inc | 21,361 | 6.8M SEK | 0.68 % |
| 36 | Egetis Therapeutics AB (publ) | 1,053,378 | 5.8M SEK | 0.58 % |
| 37 | BioInvent International AB | 228,031 | 5.1M SEK | 0.51 % |
| 38 | Pyxis Oncology Inc | 336,262 | 4.6M SEK | 0.47 % |
| 39 | Valneva SE | 122,214 | 3.8M SEK | 0.38 % |
Sector breakdown
- Health care 19.3 %
- Unattributed 80.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- SEK 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 50.6 %
- Sweden 16.0 %
- Belgium 7.6 %
- Denmark 7.1 %
- Switzerland 5.8 %
- Ireland 4.1 %
- Spain 3.6 %
- Netherlands 2.8 %
- France 2.3 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 19 | 494.6M SEK | 50.62 % |
| 2 | Sweden | 9 | 156.7M SEK | 16.03 % |
| 3 | Belgium | 2 | 74.2M SEK | 7.60 % |
| 4 | Denmark | 2 | 69.5M SEK | 7.12 % |
| 5 | Switzerland | 2 | 56.2M SEK | 5.76 % |
| 6 | Ireland | 1 | 40.5M SEK | 4.15 % |
| 7 | Spain | 1 | 35.5M SEK | 3.64 % |
| 8 | Netherlands | 1 | 26.9M SEK | 2.75 % |
| 9 | France | 2 | 22.8M SEK | 2.33 % |
Cite this page
Titelia. "Holdings of HealthInvest Small & Mid Cap Healthcare". https://titelia.com/en/funds/SE60631